SIRT1 and neoplasm: Overexpression of SIRT1 stimulated RBE-shUSP22 tumour xenograft growth—the sizes and the weights of the RBE-shUSP22 + SIRT1 tumours were twofold greater than the RBE-shUSP22 control (p < 0.05) (Fig. 6D, E and F).